EDN1 and Hypertension: Additionally, the EA-induced suppression on the pathological progression from hypertension to cardiovascular remodeling in SHR was also likely mediated via the downregulation of Ang 2, ATIR, endothelin type A receptor (ETAR), and endothelin-1 (ET-1) [34, 35].